EDITIONS
Startup

Biotech startup LeucineTech aims to make it easier for pharma companies to achieve compliance through automation

Team YS
14th Mar 2018
Add to
Shares
20
Comments
Share This
Add to
Shares
20
Comments
Share

This story is brought to you in association with Bangalore Bioinnovation Centre.

Compliance is one of the major pain points the global pharmaceutical industry is facing. Here is where LeucineTech, a Bengaluru-based, bio-technology startup, is trying to make a difference.

Started in 2017 by Vivek Gera and Abhishek Jha, the company was initially a pharma consultancy created to address the critical issue of compliance in the global pharma industry, especially when it came to the strict regulations from the US-based regulatory body the Food and Drug Administration (FDA).

Vivek Gera and Abhishek Jha

With time, the duo realised that technology and automation could work well in solving these issues, and so they came up with a product which integrates people, processes and technology to automate most workflows and takes away manual effort, reducing manual errors to help companies achieve compliance. The solution aims to integrate various stakeholders in the system and automate the process end to end.

LeucineTech is being incubated at the Bangalore Bioinnovation Centre, a state-of-the-art facility which hosts a number of biotech companies. The founders say that since being incubated at the Bangalore Bioinnovation Centre, they’ve been able to further refine their product and are close to optimising and automating the entire compliance workflow, end to end. They say that working at the facility has accelerated their journey by at least 2x to 3x.

According to the duo, earlier several companies did not want to work with them because they were an early stage startup in a fairly critical field. But working at the Bangalore Bioinnovation Centre has changed all that, and opened up several opportunities for them. In fact, today their product is being used at two of the top 10 pharmaceutical companies in India.


Report an issue
Add to
Shares
20
Comments
Share This
Add to
Shares
20
Comments
Share
Authors

Related Tags